Development of a new platform for neglected tropical disease surveillance

International Journal for Parasitology

Volumn 42, Issue 9, 2012, Pages 797-800

  Lammie, Patrick J ^a   Moss, Delynn M ^b   Brook Goodhew, E ^a   Hamlin, Katy ^a   Krolewiecki, Alejandro ^c   West, Sheila K ^d   Priest, Jeffrey W ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c UNIVERSIDAD NACIONAL DE SALTA   (Argentina)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Antibody; Elimination; Multiplex; Neglected tropical disease; Surveillance

Indexed keywords

IMMUNOGLOBULIN G;

ANTIBODY; BIOASSAY; DETECTION METHOD; DISEASE CONTROL; EPIDEMIOLOGY; HEALTH SURVEY; INFECTIOUS DISEASE; MALARIA; PUBLIC HEALTH; VACCINE; WATERBORNE DISEASE;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CRYPTOSPORIDIUM PARVUM; DRIED BLOOD SPOT TESTING; ENZYME LINKED IMMUNOSORBENT ASSAY; FILARIA; GIARDIA; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MALARIA; NEGLECTED DISEASE; NONHUMAN; PARASITE TRANSMISSION; PUBLIC HEALTH; SENSITIVITY AND SPECIFICITY; SEROLOGY; TOXOPLASMA; TROPICAL DISEASE; VALIDITY; WATER BORNE DISEASE; ZOONOSIS;

ANTIBODIES; ANTIGENS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; HUMANS; MICROSPHERES; NEGLECTED DISEASES; PARASITIC DISEASES; POPULATION SURVEILLANCE; SENSITIVITY AND SPECIFICITY; TROPICAL CLIMATE; VACCINES; VIRUS DISEASES;

EID: 84865419660     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2012.07.002     Document Type: Article

References (27)

1. Bergquist R., Vang Johansen M., Utzinger J. Diagnostic dilemmas in helminthology: what tools to use and when?. Trends Parasitol. 2009, 25:151-156.
2. Brussow H., Sidoti J., Link H., Hoang Y.K., Barclay D., Dirren H., Freire W.B. Age-specific prevalence of antibody to enterotoxigenic Escherichia coli in Ecuadorian and German children. J. Infect. Dis. 1990, 162:974-977.
3. Chandrashekar R., Curtis K.C., Ramzy R.M., Liftis F., Li B.-W., Weil G.J. Molecular cloning of Brugia malayi antigens for diagnosis of lymphatic filariasis. Mol. Biochem. Parasitol. 1994, 64:261-271.
4. Coles C.L., Seidman J.C., Levens J., Mkocha H., Munoz B., West S. Association of mass treatment withazithromycinintrachoma-endemic communities with short-term reduced risk of diarrhea in young children. Am. J. Trop. Med. Hyg. 2011, 85:691-696.
5. de Jager W., te Velthuis H., Prakken B.J., Kuis W., Rijkers G.T. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol. 2003, 10:133-139.
6. Dunbar S.A. Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin. Chim. Acta 2006, 363:71-82.
7. Flores J., DuPont H.L., Jiang Z.-D., Belkinid-Gerson J., Mohamad J.A., Carlin L.G., Padda R.S., Paredes M., Martinez-Sandoval J.F., Villa N.A., Okhuysen P.C. Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico. Int. J. Travel Med. 2008, 15:156-161.
8. Gann P.H., Neva F.A., Gam A.A. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J. Infect. Dis. 1994, 169:1076-1079.
9. Griffin S.M., Chen I.M., Fout G.S., Wade T.J., Egorov A.I. Development of a multiplex microsphere immunoassay for the quantitation of salivary antibody responses to selected waterborne pathogens. J. Immunol. Methods 2011, 364:83-93.
10. Heukelbach J., Winter B., Wilcke T., Muehlen M., Albrecht S., de Oliveira F.A., Kerr-Pontes L.R., Liesenfeld O., Feldmeier H. Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bull. World Health Organ. 2004, 82:563-571.
11. Jones L.P., Zheng H.-Q., Karron R.A., Peret T.C.T., Tsou C., Anderson L.J. Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus. Clin. Diagn. Lab. Immunol. 2002, 9:633-638.
12. Krolewiecki A.J., Ramanathan R., Fink V., McAuliffe I., Won K., Cajal S.P., Juarez M., Di Paolo A., Tapia L., Acosta N., Lee R., Lammie P., Abraham D., Nutman T.B. Improved diagnosis of Strongyloides stercoralis using recombinant antigen-based serologies in a community-wide study in northern Argentina. Clin. Vac. Immunol. 2010, 17:1624-1630.
13. Lobos E., Weiss N., Karam M., Taylor H.R., Ottesen E.A., Nutman T.B. An immunogenic Onchocerca volvulus antigen: a specific and early marker for infection. Science 1991, 251:1603-1605.
14. Moss D.M., Priest J.W., Boyd A., Weinkopff T., Kucerova Z., Beach M.J., Lammie P.J. Multiplex bead assay on sera from Haitian children enrolled in a drug study for the treatment of lymphatic filariasis. Am. J. Trop. Med. Hyg. 2011, 85:229-237.
15. Ottesen E.A., Hooper P.J., Bradley M., Biswas G. The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl. Trop. Dis. 2008, 2:e317.
16. Pickering J.W., Martins T.B., Schroder M.C., Hill H.R. Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for quantitation of antibodies to tetanus, diptheria, and Haemophilus influenza Type b. Clin. Diagn. Lab. Immunol. 2002, 9:872-876.
17. Porco T.C., Gebre T., Ayele B., House J., Keenan J., Zhou Z., Hong K.C., Stoller N., Ray K.J., Emerson P., Gaynor B.D., Lietman T.M. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA 2009, 302:962-968.
18. Priest J.W., Li A., Khan M., Arrowood M.J., Lammie P.J., Ong C.S., Roberts J.M., Isaac-Renton J. Enzyme immunoassay detection of antigen-specific immunoglobulin G antibodies in longitudinal serum samples from patients with cryptosporidiosis. Clin. Diagn. Lab. Immunol. 2001, 8:415-423.
19. Priest J.W., Moss D.M., Visvesvara G.S., Jones C.C., Li A., Isaac-Renton J.L. Multiplex assay detection of immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens. Clin. Vaccine Immunol. 2010, 11:1695-1707.
20. Reder S., Riffelmann M., Becker C., von Konig C.H.W. Measuring immunoglobulin G antibodies to tetanus toxin, diptheria toxin, and pertussis toxin with single-antigen enzyme-linked immunosorbent assays and a bead-based multiplex assay. Clin. Vaccine Immunol. 2008, 15:744-749.
21. Smith J.L., Brooker S. Impact of hookworm infection and deworming onanaemiain non-pregnant populations: a systematic review. Trop. Med. Int. Health 2010, 15:776-795.
22. Solomon A.W., Engels D., Bailey R.L., Blake I.M., Brooker S., Chen J-X., Chen J-H., Churcher T., Drakely C.J., Edwards T., Fenwick A., French K.M., Gabrielli A., Grassly N.C., Harding-Esch E.M., Holland M.J., Koukounari A., Lammie P.J., Leslie J., Mabey D.C.W., Rhajaoui M., Secor W.E., Stothard R.J., Wei H., Willingham A.L., Xiao- Zhou N., Peeling R.W. A diagnostics platform for the integrated mapping, monitoring and surveillance of neglected tropical diseases: rationale and target product profiles. PLoS Negl. Trop. Dis. 2012, 6:e1746.
23. Waterboer T., Sehr P., Michael K.M., Franceschi S., Nieland J.D., Joos T.O., Templin M.F., Pawlita M. Multiplex human papillomavirus serology based on in situ-purified gluthione S-transferase fusion proteins. Clin. Chem. 2005, 51:1845-1853.
24. Waterboer T., Sehr P., Pawlita M. Suppression of non-specific binding in serological Luminex assays. J. Immunol. Methods 2006, 309:200-204.
25. World Health Organization, 2010. Working to overcome the global impact of neglected tropical disease.
26. World Health Organization, 2011a. Global programme to eliminate lymphatic filariasis: progress on mass drug administration, 2010. Weekly Epid. Record 35, 377-388.
27. World Health Organization, 2011b. Global programme to eliminate lymphatic filariasis: Monitoring and epidemiological assessment of mass drug administration.